文献速递生殖医学

使用精子玻璃化装置冷冻少量精子的新解决方案

A novel solution for freezing small numbers of spermatozoa using a sperm vitrification device.
PubMed 文献 · Hum Reprod · 2018-01-01

本研究评估新型精子玻璃化装置(SpermVD)冷冻非梗阻性无精子症患者少量精子的效率。前瞻性队列纳入44例,冷冻631条精子,复苏回收率96%,受精率59%,55%取卵周期获临床妊娠。

要点

  • SpermVD冷冻少量精子复苏回收率96%,复苏后搜索时间从数小时缩短至数分钟。
  • 44例取卵周期中24例(55%)获临床妊娠,分娩率32%,流产率29%。
  • 作者认为该装置可能使非梗阻性无精子症患者TESE后常规使用冷冻精子,避免重复手术。

核心结论

  • 新型SpermVD是冷冻少量精子的高效简便载体方法,复苏回收率96%,复苏后精子可用于受精。

研究设计与样本

  • 可行性实验及前瞻性队列研究,2015年至2017年在两家门诊生育IVF诊所纳入44例非梗阻性无精子症男性的ICSI周期。

主要发现

  • 用SpermVD玻璃化631条精子,其中540条(86%)为活动精子,每例平均冷冻14.3±9.3条。
  • 复苏后回收607条精子,回收率96%,平均复苏13.8±9.2条。
  • 复苏活动精子180条,占所有冷冻活动精子的33%。
  • 受精率59%;44次取卵中24次(55%)获临床妊娠;分娩率32%(不含3例持续妊娠),流产率29%。

临床怎么用

  • 作者认为SpermVD可能使非梗阻性无精子症患者TESE后常规使用冷冻精子,避免重复TESE手术。
  • 作者认为非梗阻性无精子症患者IVF周期前常规冷冻获取的精子可能避免周期取消风险,减少不必要的取卵程序。

局限性

  • 虽然展示了44例,但更大队列将提供更多信息。
  • 仅冷冻精液中的活动精子而未冷冻不活动精子,限制了对该装置用于此来源不活动精子效果的了解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does a novel sperm vitrification device (SpermVD) provide an efficient method for freezing a small number of human spermatozoa from men suffering from non-obstructive azoospermia? SUMMARY ANSWER: The novel SpermVD is an efficient and simple carrier method for freezing a small number of spermatozoa in low-volume droplets, reducing post-thaw search time from hours to minutes, allowing a 96% recovery rate and leading to successful use of sperm for fertilization. WHAT IS KNOWN ALREADY: Previous methods for cryopreservation of small numbers of human spermatozoa (e.g. mini-straws, ICSI pipette, alginate beads, cryoloop) have been proposed as a solution for cases of severe male infertility. Many drawbacks have prevented their widespread use, including cumbersome preparation and sperm retrieval procedures, and the fact that the thawed spermatozoa are not immediately available for micromanipulation and required additional treatment which posed excess risk of harm. STUDY DESIGN, SIZE, DURATION: We conducted a feasibility experiment of the novel SpermVD and a prospective cohort study of ICSI cycles in men suffering from non-obstructive azoospermia in two outpatient fertility IVF clinics, from 2015 through 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: All patients underwent extended ejaculate search prior to the day of oocyte retrieval, and any single motile spermatozoa found was transferred to 0.8 μl droplets of 1:1 washing medium/cryoprotectant on the SpermVD, then plunged into liquid nitrogen for cryopreservation. In patients with non-obstructive azoospermia who underwent surgical TESE, both the motile and immotile spermatozoa found underwent cryopreservation using the SpermVD. On the day of oocyte retrieval, the SpermVD was thawed, directly transfered to the ICSI plate and retrieved spermatozoa were used for the ICSI procedure. MAIN RESULTS AND THE ROLE OF CHANCE: The prospective cohort included 44 cases. We used the SpermVD to vitrify 631 spermatozoa, of which 540 (86%) were motile. The average number of frozen spermatozoa per patient was 14.3 ± 9.3. After thawing, we retrieved 607 spermatozoa, producing a recovery rate of 96%. The average number of thawed spermatozoa was 13.8 ± 9.2. The recovery of 180 thawed motile sperm accounted for 33% of all frozen motile spermatozoa. The fertilization rate was 59%. Of 44 oocyte retrieval procedures, 24 (55%) clinical pregnancies were achieved. The delivery rate (not including three ongoing pregnancies) was 32% and the miscarriage rate was 29%. LIMITATIONS, REASONS FOR CAUTION: Although we presented the SpermVD on 44 cases, a larger cohort would provide more information. Moreover, we cryopreserved only motile sperm from the ejaculates and not immotile sperm, thus limiting the knowledge regarding the efficacy of the VD for immotile sperm from this source. WIDER IMPLICATIONS OF THE FINDINGS: The novel SpermVD is a simple efficient carrier, optimizing the protocol for freezing a small number of spermatozoa. It may allow for the routine use of frozen spermatozoa after TESE for men suffering from non-obstructive azoospermia and thus avoid repeated TESE surgeries. Furthermore, in cases of non-obstructive azoospermia, routine cryopreservation of the retrieved spermatozoa prior to the IVF cycle may avoid the risk of cycle cancelation and thus decrease the number of unnecessary oocyte retrieval procedures. STUDY FUNDING/COMPETING INTEREST(S): There was no external funding. There are no competing interests. TRIAL REGISTRATION NUMBER: IRB no 00119-16-ASMC.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Berkovitz A, Miller N, Silberman M, et al. A novel solution for freezing small numbers of spermatozoa using a sperm vitrification device. Hum Reprod. 2018. PMID: 30285105. doi:10.1093/humrep/dey304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。